Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas.
Department of Epidemiology, Human Genetics and Environmental Sciences, the University of Texas Health Science Center-Houston, School of Public Health, Brownsville Campus, Brownsville, Texas.
Am J Cardiol. 2023 Oct 15;205:75-83. doi: 10.1016/j.amjcard.2023.07.165. Epub 2023 Aug 16.
Endothelial dysfunction assessed by impaired brachial flow-mediated dilation (FMD) predicts incident cardiovascular disease (CVD). We have previously shown that clustering of diabetes mellitus, obesity, and metabolic syndrome in young Hispanic patients was associated with subclinical atherosclerosis. This study aimed to assess determinants of impaired FMD response (%FMD), an earlier marker of atherosclerosis, in a population-based sample of asymptomatic Mexican Americans. Cardiometabolic biomarkers and FMD were obtained from 960 Cameron County Hispanic Cohort participants. Gender-specific median values of %FMD were used to categorize participants into those with %FMD below or above the median. The sample was further stratified into those younger and older than 55 years. Survey-weighted logistic regression analyses were conducted to evaluate the effects of cardiometabolic biomarkers on the %FMD groups. The low %FMD group was significantly older, had higher visceral adipose tissue, systolic blood pressure, or plasma glucose, and had metabolic syndrome compared with those in the high %FMD group. Multivariable-adjusted age-stratified logistic regression analyses showed that in older participants, male gender (odds ratio [OR] = 2.4 [1.4 to 4.2]) and having hypertension (OR = 2.3 [1.3 to 4.3]) or prediabetes mellitus (OR = 3.4 [1.5 to 7.5]) remained significantly associated with odds of low %FMD. In younger participants, high low-density lipoprotein (OR = 2.8 [1.6 to 4.9]) or having the metabolic syndrome (OR = 1.9 [1.1 to 3.6]) were significantly associated with odds of low %FMD. In conclusion, we found age-dependent associations between cardiometabolic biomarkers and an FMD response below the gender-specific median in a sample composed of Mexican Americans without previous CVD. Targeting specific risk factors by age may mitigate progression to incident CVD in this high-risk racial disparity group.
通过受损的肱动脉血流介导的扩张(FMD)评估的内皮功能障碍可预测心血管疾病(CVD)的发生。我们之前已经表明,在年轻的西班牙裔患者中,糖尿病、肥胖和代谢综合征的聚集与亚临床动脉粥样硬化有关。本研究旨在评估代谢生物标志物与无症状墨西哥裔美国人人群中动脉粥样硬化早期标志物肱动脉血流介导的扩张(FMD)反应受损的相关性。从 960 名卡梅隆县西班牙裔队列参与者中获得了心脏代谢生物标志物和 FMD。使用 %FMD 的性别特异性中位数将参与者分为 %FMD 低于或高于中位数的组。该样本进一步分为年龄小于或大于 55 岁的组。进行了经过调查加权的逻辑回归分析,以评估心脏代谢生物标志物对 %FMD 组的影响。低 %FMD 组年龄较大,内脏脂肪组织、收缩压或血浆葡萄糖较高,并且代谢综合征的发生率较高。多变量调整的年龄分层逻辑回归分析表明,在年龄较大的参与者中,男性(比值比 [OR] = 2.4 [1.4 至 4.2])和高血压(OR = 2.3 [1.3 至 4.3])或糖尿病前期(OR = 3.4 [1.5 至 7.5])与低 %FMD 的可能性仍显著相关。在年龄较小的参与者中,高 LDL (OR = 2.8 [1.6 至 4.9])或患有代谢综合征(OR = 1.9 [1.1 至 3.6])与低 %FMD 的可能性显著相关。总之,我们在一个没有先前 CVD 的墨西哥裔美国人样本中发现了心脏代谢生物标志物与 FMD 反应低于性别特异性中位数之间的年龄依赖性关联。根据年龄针对特定危险因素可能会减轻该高风险种族差异人群中 CVD 事件的发生。